Skip to main content

Advertisement

Log in

Prognostic Indices and Mortality Prediction in COPD Caused by Biomass Smoke Exposure

  • Published:
Lung Aims and scope Submit manuscript

Abstract

Introduction

Little is known about survival and prognostic factors in chronic obstructive pulmonary disease (COPD) due to biomass smoke exposure (BS-COPD).

Objectives

(1) To determine the value of two indices of COPD severity: BODEx (body mass index, obstruction, dyspnea, and previous severe exacerbations) and Global Initiative for Chronic Obstructive Lung Disease (GOLD) categories system (ABCD) to predict all-cause mortality in BS-COPD, compared with COPD due to tobacco (T-COPD); (2) to verify the usefulness of 2 comorbidity indices, Charlson index and COTE (COPD comorbidity index); and (3) to put side by side the value of these indices.

Methods

612 consecutive COPD patients were retrospectively studied. Prognostic factors were evaluated taking into account the exposure to biomass or tobacco smoke. The relative predictive values of the prognostic indices were compared using receiver-operating characteristic analysis.

Results

Mortality in the BS-COPD and T-COPD groups was not significantly different, when sex was taken into account. BODEx, Charlson and COTE indices—but not type of exposure—predicted mortality in multivariate analysis. The value of the C-statistic for the BODEx index was not different than that of GOLD ABCD for BS-COPD, but was higher for T-COPD. The discriminatory value of the Charlson index was higher than that of COTE for BS-COPD, but no significant differences were found for T-COPD.

Conclusions

Multidimensional indices of COPD severity and comorbidity predict all-cause mortality in BS-COPD. The behavior of the different indices is different for BS-COPD and T-COPD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Global Strategy for the Diagnosis, Management and Prevention of COPD Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2014. http://www.goldcopd.org/

  2. Celli BR, Cote CG, Marín JM, Casanova C, Montes de Oca M, Mendez RA et al (2004) The body-mass index, airflow obstruction, dyspnea and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350:1005–1012

    Article  CAS  PubMed  Google Scholar 

  3. Miravitlles M, Soler-Cataluña JJ, Calle M, Molina J, Almagro P, Quintano JA et al (2012) Spanish COPD guidelines (GesEPOC): pharmacological treatment of stable COPD. Spanish Society of Pulmonology and Thoracic Surgery. Arch Bronconeumol 48:247–257

    PubMed  Google Scholar 

  4. Soler-Cataluña JJ, Martínez-García MA, SánchezSánchez L, PerpiñáTordera M, RománSánchez P (2009) Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients. Resp Med 103:692–699

    Article  Google Scholar 

  5. Charlson ME, Pompei P, Ales K, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–438

    Article  CAS  PubMed  Google Scholar 

  6. Divo M, Cote C, de Torres JP, Casanova C, Marín JM, Pinto-Plata V et al (2012) Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 186:155–161

    Article  PubMed  Google Scholar 

  7. Salvi SS, Barnes PJ (2009) Chronic obstructive pulmonary disease in non-smokers. Lancet 374:733–743

    Article  PubMed  Google Scholar 

  8. De Torres JP, Cote CG, López MV, Casanova C, Diaz O, Marín JM et al (2009) Sex differences in mortality in patients with COPD. Eur Respir J 33:528–535

    Article  PubMed  Google Scholar 

  9. DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845

    Article  CAS  PubMed  Google Scholar 

  10. Orozco-Levi M, García-Aymerich J, Villar J, Ramírez-Sarmiento A, Antó JM, Gea J (2006) Wood smoke exposure and risk of chronic obstructive pulmonary disease. Eur Respir J 27:542–546

    Article  CAS  PubMed  Google Scholar 

  11. Golpe R, Sanjuán-López P, Cano-Jiménez E, Castro-Añón O, Pérez-de-Llano LA (2014) Distribution of clinical phenotypes in patients with chronic obstructive pulmonary disease caused by biomass and tobacco smoke. Arch Bronconeumol 50:318–324

    Article  PubMed  Google Scholar 

  12. Camp PG, Ramírez-Venegas A, Sansores RH, Alva LF, McDougall JE, Sin DD et al (2014) COPD phenotypes in biomass smoke-versus tobacco smoke-exposed Mexican women. Eur Respir J 43:725–734

    Article  PubMed  Google Scholar 

  13. Rivera RM, Cosio MG, Ghezzo H, Salazar M, Pérez-Padilla R (2008) Comparison of lung morphology in COPD secondary to cigarette and biomass smoke. Int J Tuberc Lung Dis 12:972–977

    CAS  PubMed  Google Scholar 

  14. Ramírez-Venegas A, Sansores RH, Quintana-Carrillo RH, Velázquez-Uncal M, Hernández-Zenteno RJ, Sánchez-Romero C et al (2014) FEV1 decline in patients with chronic obstructive pulmonary disease associated with biomass exposure. Am J Respir Crit Care Med 190:996–1002

    Article  PubMed  Google Scholar 

  15. Ramírez-Venegas A, Sansores RH, Pérez-Padilla R, Regalado J, Velázquez A, Sánchez C et al (2006) Survival of patients with chronic obstructive pulmonary disease due to biomass smoke and tobacco. Am J Respir Crit Care Med 173:393–397

    Article  PubMed  Google Scholar 

  16. Dijk WD, Lv Bemt, Sv Haak-Rongen, Bischoff E, Cv Weel, Veen JC et al (2011) Multidimensional prognostic indices for use in COPD patient care. A systematic review. Respir Res 12:151

    Article  PubMed Central  PubMed  Google Scholar 

  17. Soriano JB, Alfageme I, Almagro P et al (2013) Distribution and prognostic validity of the new global initiative for chronic obstructive lung disease grading classification. Chest 143:694–702

    PubMed  Google Scholar 

  18. De Torres JP, Casanova C, Marin JM, Pinto-Plata V, Divo M, Zulueta JJ et al (2014) Prognostic evaluation of COPD patients: GOLD 2011 versus BODE and the COPD comorbidity index COTE. Thorax 69:799–804

    Article  PubMed  Google Scholar 

  19. Soriano JB, Visick GT, Muellerova H, Payvandi N, Hansell AL (2005) Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest 128:2099–2107

    Article  PubMed  Google Scholar 

  20. Terzano C, Conti V, Di Stefano F, Petroianni A, Ceccarelli D, Graziani E et al (2010) Comorbidity, hospitalization, and mortality in COPD: results from a longitudinal study. Lung 188:321–329

    Article  PubMed  Google Scholar 

  21. Almagro P, Cabrera FJ, Diez J, Boixeda R, Alonso Ortiz MB, Murio C et al (2012) Comorbidities and short-term prognosis in patients hospitalized for acute exacerbations of COPD: the EPOC en servicios de medicina interna (ESMI) study. Chest 142:1126–1133

    Article  PubMed  Google Scholar 

Download references

Compliance with Ethical Standards

The study was approved by our local ethical committee (Registry number: CAEI Galicia 2014/016) and was performed in accordance with the 1964 Declaration of Helsinki and its later amendments.

Conflict of interest

The authors declare that they not have conflicts of interest, financial or otherwise, regarding the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rafael Golpe.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Golpe, R., Mengual-Macenlle, N., Sanjuán-López, P. et al. Prognostic Indices and Mortality Prediction in COPD Caused by Biomass Smoke Exposure. Lung 193, 497–503 (2015). https://doi.org/10.1007/s00408-015-9731-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00408-015-9731-9

Keywords

Navigation